Regeneus (ASX:RGS), a clinical-stage regenerative medicine company, today announced that the first patient has been enrolled and safely treated in the first clinical trial of RGSH4K, the company's autologous tumour vaccine product for the treatment of solid tumours.
Compumedics Limited (ASX:CMP) is pleased to announce the release of an initiating research report by PAC partners.
Erin Resources Ltd (ASX:ERI) is pleased to provide investors an update on the development of MGC Pharmaceuticals' (MGC) new CBD based skin care formula for the effective relief for Psoriatic skin.
Regeneus Ltd (ASX:RGS) are pleased to provide the Company's Annual Report for 2015 to shareholders.
Regeneus Ltd (ASX:RGS), a clinical-stage regenerative medicine company, today reported that it has received $3.4m from the Australian Government's Research and Development Tax Incentive Program for activities conducted during the 2015 financial year.
Rhinomed Ltd (ASX:RNO) has launched two products into global markets during the financial year: launching our new sleep quality aid, Mute(TM) into the global sleep device market and a new generation Turbine(TM) sports product in response to feedback from users.
Compumedics Limited (ASX:CMP) is pleased to announce that it has secured a new three-year contract for the distribution of Compumedics' sleep diagnostic and monitoring systems across provinces in and around Shanghai with one of its long-term distribution partners in China, ZhiNuo.
